Covered recipient · General Payments record
CARL D ROBINSON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$6,924.97
- Reported across 190 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.04 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.08 | 6 |
| Biogen, Inc. | $41.15 | 2 |
| TG THERAPEUTICS, INC. | $24.30 | 1 |
| EMD Serono, Inc. | $19.67 | 1 |
| PFIZER INC. | $17.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $19.49 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998642537 | CMS |
| AbbVie Inc. | $22.79 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998642543 | CMS |
| AbbVie Inc. | $15.87 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998642547 | CMS |
| AbbVie Inc. | $33.68 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998642553 | CMS |
| AbbVie Inc. | $15.42 | 09/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998642559 | CMS |
| AbbVie Inc. | $26.83 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998642565 | CMS |
| Biogen, Inc. | $18.71 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012266233 | CMS |
| Biogen, Inc. | $22.44 | 04/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012144913 | CMS |
| EMD Serono, Inc. | $19.67 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032429195 | CMS |
| Novartis Pharmaceuticals Corporation | $15.43 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992903031 | CMS |
| PFIZER INC. | $17.41 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050518493 | CMS |
| TG Therapeutics, Inc. | $24.30 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051504047 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.